Flt-3/Flk-2 (SF1.340) Antibody sc-19635 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemFlt-3/Flk-2 (SF1.340) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-19635
Antibody TypePrimary Antibodies
NCBI Gene AliasesCD135, FLK-2, FLK2, STK1
Quantity200 µg/ml
CloneSF1.340
ApplicationsWB, IP, IF, FCM
Reactivityhuman
FormatPurified
ClonalityMonoclonal
Conjugate/TagUnconjugated
Hostmouse
NCBI Full Gene Namefms related receptor tyrosine kinase 3
TargetFlt-3/Flk-2
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Golgi retention and oncogenic KIT signaling via PLCγ2-PKD2-PI4KIIIβ activation in gastrointestinal stromal tumor cellsCell reportsSeptember 26, 2023Obata Y, Kurokawa K, Tojima T, Natsume M, Shiina I, Takahashi T, Abe R, Nakano A, Nishida T.

(2) Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutationJournal of translational medicineJuly 6, 2022Xu D, Chen Y, Yang Y, Yin Z, Huang C, Wang Q, Jiang L, Jiang X, Yin C, Liu Q, et al.CAS #9661) were purchased from Cell Signaling Technology. Against ERK2 (CAS #sc-1647) and FLT3 (CAS #sc-19635) were from Santa Cruz Biotechnology. Anti-GAPHD (CAS #G9545) was purchased from Millipore Sigma. AML

(3) FLT3-ITD transduces autonomous growth signals during its biosynthetic trafficking in acute myelogenous leukemia cellsScientific reportsNovember 22, 2021Yamawaki K, Shiina I, Murata T, Tateyama S, Maekawa Y, Niwa M, Shimonaka M, Okamoto K, Suzuki T, Nishida T, et al.

(4) Deficiency of core fucosylation activates cellular signaling dependent on FLT3 expression in a Ba/F3 cell systemFASEB journal : official publication of the Federation of American Societies for Experimental BiologyFebruary 1, 2020Duan C, Fukuda T, Isaji T, Qi F, Yang J, Wang Y, Takahashi S, Gu J.

(5) The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptorScientific reportsJune 27, 2016Sandhöfer N, Bauer J, Reiter K, Dufour A, Rothenberg M, Konstandin NP, Zellmeier E, Tizazu B, Greif PA, Metzeler KH, et al.

(6) FMS-like tyrosine kinase 3 (FLT3) inhibitors: Molecular docking and experimental studiesEuropean journal of pharmacologyApril 5, 2016Mashkani B, Tanipour MH, Saadatmandzadeh M, Ashman LK, Griffith R.

(7) Differences in growth promotion, drug response and intracellular protein trafficking of FLT3 mutantsIranian journal of basic medical sciencesNovember 1, 2014Mashkani B, Griffith R, Ashman L.homogenous population. FLT3 expression on sorted cells was confirmed by flow cytometry using FLk2/FLT3 (sc-19635) antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and sheep anti-mouse IgG conjugated with PE (Chemicon,

(8) The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulationPLoS pathogensApril 1, 2011Karki R, Lang SM, Means RE.

(9) FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657Leukemia researchOctober 1, 2010Goemans BF, Zwaan CM, Cloos J, de Lange D, Loonen AH, Reinhardt D, Hählen K, Gibson BE, Creutzig U, Kaspers GJ.

(10) Anchoring of FLT3 in the endoplasmic reticulum alters signaling qualityBloodApril 9, 2009Schmidt-Arras D, Böhmer SA, Koch S, Müller JP, Blei L, Cornils H, Bauer R, Korasikha S, Thiede C, Böhmer FD.

(11) Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3Cancer researchMay 15, 2004George P, Bali P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Fiskus W, Scuto A, Annavarapu S, et al.

(12) Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptorsThe Journal of experimental medicineJanuary 5, 2004Basso K, Liso A, Tiacci E, Benedetti R, Pulsoni A, Foa R, Di Raimondo F, Ambrosetti A, Califano A, Klein U, et al.

Be the First to Write a Review!

Flt-3/Flk-2 (SF1.340) Antibody

Flt-3/Flk-2 (SF1.340) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (12)

Reviews

Flt-3/Flk-2 (SF1.340) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map